Which companies discussed Clinical Trials in earnings calls?

1,095 companies mentioned clinical trials across 3,814 earnings calls over the past year, spanning 10 sectors. The most active were Roivant Sciences Ltd. (22 calls), Merck KGaA (21 calls), Ionis Pharmaceuticals, Inc. (20 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning Clinical Trials
2024Q395
2024Q41,004
2025Q11,132
2025Q2795
2025Q3921
2025Q4939
2026Q11,108
2026Q2990
2026Q3681

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Roivant Sciences Ltd. ROIV Health Care 22 Sep 9, 2026
Merck KGaA MRK Health Care 21 Sep 9, 2026
Ionis Pharmaceuticals, Inc. IONS Health Care 20 Sep 10, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 17 Sep 10, 2026
Incyte Corporation INCY Health Care 17 Sep 10, 2026
Biogen Inc. BIIB Health Care 17 Sep 9, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 17 Sep 9, 2026
Exelixis, Inc. EXEL Health Care 17 Sep 9, 2026
Jazz Pharmaceuticals plc JAZZ Health Care 16 Sep 10, 2026
Neurocrine Biosciences, Inc. NBIX Health Care 16 Sep 10, 2026
United Therapeutics Corporation UTHR Health Care 16 Sep 9, 2026
Gilead Sciences, Inc. GILD Health Care 15 Sep 10, 2026
Amgen Inc. AMGN Health Care 15 Sep 10, 2026
Insmed Incorporated INSM Health Care 15 Sep 9, 2026
PTC Therapeutics, Inc. PTCT Health Care 15 Aug 12, 2026
Johnson & Johnson JNJ Health Care 14 Sep 9, 2026
AbbVie Inc. ABBV Health Care 14 Sep 9, 2026
Nuvation Bio Inc. NUVB Health Care 14 Sep 9, 2026
Ultragenyx Pharmaceutical Inc. RARE Health Care 14 Aug 19, 2026
Natera, Inc. NTRA Health Care 14 Aug 12, 2026
Kura Oncology, Inc. KURA Health Care 14 Aug 12, 2026
Recursion Pharmaceuticals, Inc. RXRX Health Care 14 Aug 11, 2026
Moderna, Inc. MRNA Health Care 14 Jul 31, 2026
BridgeBio Pharma, Inc. BBIO Health Care 13 Sep 10, 2026
Axsome Therapeutics, Inc. AXSM Health Care 13 Sep 10, 2026
GSK plc GSK Health Care 13 Sep 9, 2026
Alnylam Pharmaceuticals, Inc. ALNY Health Care 13 Sep 8, 2026
Rhythm Pharmaceuticals, Inc. RYTM Health Care 13 Aug 4, 2026
Boston Scientific Corporation BSX Health Care 12 Sep 10, 2026
Cytokinetics, Incorporated CYTK Health Care 12 Sep 9, 2026
Cencora, Inc. COR Health Care 12 Sep 8, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 12 Aug 31, 2026
AbCellera Biologics Inc. ABCL Health Care 12 Aug 10, 2026
Genmab A/S GMAB Health Care 12 Aug 6, 2026
Denali Therapeutics Inc. DNLI Health Care 12 Aug 6, 2026
Roche Holding AG ROG Health Care 12 Jul 23, 2026
Syndax Pharmaceuticals, Inc. SNDX Health Care 11 Sep 10, 2026
Scholar Rock Holding Corporation SRRK Health Care 11 Sep 10, 2026
Celcuity Inc. CELC Health Care 11 Sep 9, 2026
Revolution Medicines, Inc. RVMD Health Care 11 Aug 26, 2026
argenx SE ARGX Health Care 11 Aug 17, 2026
Absci Corporation ABSI Health Care 11 Aug 11, 2026
Wave Life Sciences Ltd. WVE Health Care 11 Aug 11, 2026
Pfizer Inc. PFE Health Care 11 Aug 4, 2026
Bristol-Myers Squibb Company BMY Health Care 11 Jul 30, 2026
Summit Therapeutics Inc. SMMT Health Care 11 Jul 23, 2026
Bio-Techne Corporation TECH Health Care 11 May 6, 2026
Inovio Pharmaceuticals, Inc. INO Health Care 10 Sep 11, 2026
BioMarin Pharmaceutical Inc. BMRN Health Care 10 Sep 10, 2026
Kymera Therapeutics, Inc. KYMR Health Care 10 Sep 10, 2026

Representative quotes

…natural occurring endogenous NK cells in the body. Operator (Operator): All set. I appreciate the explanation. So Jeffrey Miller (Executives): In that early clinical trial that we completed, we were very excited starting at doses of 25-microgram per kilogram per day of the continuously infused products…
GT Biopharma, Inc. (GTBP), September 11, 2026. Read the full transcript →
…pretty rocky back in November. And you can also see here with the cutting of NIH funding. We saw some clinical trials getting canceled and since we have a decent share of the market, of course, we get hit as well. Majorly, we also saw some…
ChemoMetec A/S (CHEMM), September 11, 2026. Read the full transcript →
…that underpins our BLA submission. So when we look at what we saw coming out of the trial, we were very pleased to see what we saw as promising clinical benefit. So when you look at in terms of the 50% to 100% reduction in surgeries prior…
Inovio Pharmaceuticals, Inc. (INO), September 11, 2026. Read the full transcript →
…allocation of resources. But it also reflects the broader clinical interest in asking what BOT+BAL may do before surgery and creates additional clinical trial access to patients. At the same time, physician interest in accessing BOT+BAL outside of clinical trials also continues. We've had geographic…
Agenus Inc. (AGEN), September 10, 2026. Read the full transcript →

Frequently asked questions

What is Clinical Trials and why are companies discussing it?

Pipeline readouts, trial milestones and FDA commentary driving biotech and pharma valuations.

Which company mentioned clinical trials most in the past year?

Roivant Sciences Ltd. (ROIV) led with 22 calls referencing clinical trials, most recently on September 9, 2026.

How can I track clinical trials mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Clinical Trials by sector

Related healthcare themes

Last updated: September 12, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (clinical trial, clinical trial, clinical trials, phase 3). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.